CY2011018I1 - Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος - Google Patents
Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεοςInfo
- Publication number
- CY2011018I1 CY2011018I1 CY2011018C CY2011018C CY2011018I1 CY 2011018 I1 CY2011018 I1 CY 2011018I1 CY 2011018 C CY2011018 C CY 2011018C CY 2011018 C CY2011018 C CY 2011018C CY 2011018 I1 CY2011018 I1 CY 2011018I1
- Authority
- CY
- Cyprus
- Prior art keywords
- nenean
- cyclopopyl
- kyan
- diazadicyclo
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004015981A DE102004015981A1 (de) | 2004-04-01 | 2004-04-01 | Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| PCT/EP2005/002953 WO2005097789A1 (de) | 2004-04-01 | 2005-03-19 | Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2011018I1 true CY2011018I1 (el) | 2016-12-14 |
Family
ID=34962324
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100090T CY1109762T1 (el) | 2004-04-01 | 2010-01-29 | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος |
| CY2011018C CY2011018I1 (el) | 2004-04-01 | 2011-10-11 | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100090T CY1109762T1 (el) | 2004-04-01 | 2010-01-29 | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US7977484B2 (el) |
| EP (1) | EP1737859B1 (el) |
| JP (1) | JP5190259B2 (el) |
| KR (1) | KR101217678B1 (el) |
| CN (1) | CN100591681C (el) |
| AR (2) | AR048099A1 (el) |
| AT (1) | ATE450536T1 (el) |
| AU (1) | AU2005231918B2 (el) |
| BR (1) | BRPI0509529B8 (el) |
| CA (1) | CA2561635C (el) |
| CY (2) | CY1109762T1 (el) |
| DE (3) | DE102004015981A1 (el) |
| DK (1) | DK1737859T3 (el) |
| ES (1) | ES2335899T3 (el) |
| GT (1) | GT200500043A (el) |
| HK (1) | HK1104537A1 (el) |
| HR (1) | HRP20100097T1 (el) |
| IL (1) | IL178353A (el) |
| MY (1) | MY140998A (el) |
| NO (1) | NO337279B1 (el) |
| NZ (1) | NZ550226A (el) |
| PE (1) | PE20060170A1 (el) |
| PL (1) | PL1737859T3 (el) |
| PT (1) | PT1737859E (el) |
| RU (1) | RU2383543C2 (el) |
| SI (1) | SI1737859T1 (el) |
| SV (1) | SV2006002070A (el) |
| TW (1) | TWI350755B (el) |
| UA (1) | UA84329C2 (el) |
| UY (1) | UY28828A1 (el) |
| WO (1) | WO2005097789A1 (el) |
| ZA (1) | ZA200608072B (el) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
| DE102007026550A1 (de) | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
| KR102504435B1 (ko) | 2017-02-13 | 2023-02-27 | 바이엘 애니멀 헬스 게엠베하 | 프라도플록사신을 함유하는 액체 조성물 |
| CN115710267A (zh) * | 2022-11-30 | 2023-02-24 | 天津大学 | 一种普拉沙星水合物晶体及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE228130T1 (de) * | 1996-02-23 | 2002-12-15 | Bayer Ag | Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0)-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3- hinolincarbonsäuren und ihre derivate |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19854355A1 (de) | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19854356A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE19908449A1 (de) | 1999-02-26 | 2000-08-31 | Bayer Ag | Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure |
| DE19908448A1 (de) | 1999-02-26 | 2000-08-31 | Bayer Ag | Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
-
2004
- 2004-04-01 DE DE102004015981A patent/DE102004015981A1/de not_active Withdrawn
-
2005
- 2005-03-10 GT GT200500043A patent/GT200500043A/es unknown
- 2005-03-15 AR ARP050101004A patent/AR048099A1/es not_active Application Discontinuation
- 2005-03-19 US US11/547,420 patent/US7977484B2/en active Active
- 2005-03-19 ES ES05716236T patent/ES2335899T3/es active Active
- 2005-03-19 AT AT05716236T patent/ATE450536T1/de active
- 2005-03-19 NZ NZ550226A patent/NZ550226A/en unknown
- 2005-03-19 PL PL05716236T patent/PL1737859T3/pl unknown
- 2005-03-19 EP EP05716236A patent/EP1737859B1/de active Active
- 2005-03-19 PT PT05716236T patent/PT1737859E/pt unknown
- 2005-03-19 SI SI200530913T patent/SI1737859T1/sl unknown
- 2005-03-19 DK DK05716236.4T patent/DK1737859T3/da active
- 2005-03-19 DE DE502005008620T patent/DE502005008620D1/de active Active
- 2005-03-19 WO PCT/EP2005/002953 patent/WO2005097789A1/de active Application Filing
- 2005-03-19 CA CA2561635A patent/CA2561635C/en active Active
- 2005-03-19 RU RU2006138362/04A patent/RU2383543C2/ru active
- 2005-03-19 AU AU2005231918A patent/AU2005231918B2/en active Active
- 2005-03-19 UA UAA200611491A patent/UA84329C2/ru unknown
- 2005-03-19 JP JP2007505435A patent/JP5190259B2/ja active Active
- 2005-03-19 CN CN200580010668A patent/CN100591681C/zh active Active
- 2005-03-19 BR BRPI0509529A patent/BRPI0509529B8/pt active IP Right Grant
- 2005-03-30 UY UY28828A patent/UY28828A1/es not_active Application Discontinuation
- 2005-03-30 MY MYPI20051428A patent/MY140998A/en unknown
- 2005-03-31 TW TW094110161A patent/TWI350755B/zh active
- 2005-03-31 PE PE2005000369A patent/PE20060170A1/es not_active Application Discontinuation
- 2005-04-01 SV SV2005002070A patent/SV2006002070A/es unknown
-
2006
- 2006-09-28 ZA ZA2006/08072A patent/ZA200608072B/en unknown
- 2006-09-28 IL IL178353A patent/IL178353A/en active IP Right Grant
- 2006-10-26 KR KR1020067022260A patent/KR101217678B1/ko active IP Right Grant
- 2006-10-31 NO NO20064988A patent/NO337279B1/no unknown
-
2007
- 2007-09-05 HK HK07109664.9A patent/HK1104537A1/xx unknown
-
2010
- 2010-01-29 CY CY20101100090T patent/CY1109762T1/el unknown
- 2010-02-24 HR HR20100097T patent/HRP20100097T1/hr unknown
-
2011
- 2011-10-11 CY CY2011018C patent/CY2011018I1/el unknown
- 2011-10-11 DE DE201112100055 patent/DE122011100055I1/de active Pending
-
2016
- 2016-06-28 AR ARP160101954A patent/AR105177A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2017051I2 (no) | Kariprazin, eventuelt i form av et salt | |
| DK1660431T3 (da) | Phenoxyeddikesyrederivater | |
| WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
| DE602005018076D1 (de) | Enantioselektive herstellung von chinolin-derivaten | |
| ZA200704789B (en) | Novel anthranilic acid derivative or salt thereof | |
| AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| IL176913A0 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| DK1692242T3 (da) | Viskoelastisk syre | |
| ATE461285T1 (de) | Herstellung von tnfr-fc | |
| NO20052761D0 (no) | Spirocykliske cykloheksanderivater. | |
| ITRM20050287A1 (it) | Polsino per orologio. | |
| AP2007004001A0 (en) | Novel dicarboxylic acid derivatives | |
| FR2910230B3 (fr) | Methodes de biofertilisations pour ameliorer la stabilite des rendements de grandes cultures agronomiques. | |
| IL183591A0 (en) | Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives | |
| DE602005004215D1 (de) | Herstellung von cis-1,4-Polybutadien | |
| NO20053753D0 (no) | Karboksylsyreforbindelser. | |
| CY2011018I1 (el) | Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος | |
| DE602005010986D1 (de) | Neue pyrrolidin-3,4-dicarbonsäureamidderivate | |
| DK1838683T3 (da) | Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater | |
| DE60324703D1 (de) | Barbitursäure derivaten. | |
| DE502004003170D1 (de) | Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure | |
| NO20044629L (no) | Fremgangsmate til fremstilling av sure salter av gemifloksasin. | |
| DK1768988T3 (da) | Hidtil ukendte phenyl-borsyre-derivater samt fremgangsmåder til fremstilling deraf | |
| IL181417A0 (en) | Chiral 3-halophthalic acid derivatives | |
| DE602004019824D1 (de) | Modifizierte ethylendiamin-n,n'-dibernsteinsäure:ethylendiamin-lyase |